(Q37763190)

22 August 2017

1 reference

title

Generation and genetic modification of induced pluripotent stem cells (English)

1 reference

22 August 2017

1

Axel Schambach

0 references

Toni Cathomen

series ordinal

4

object named as

Toni Cathomen

1 reference

22 August 2017

Tobias Cantz

2

1 reference

PubMed ID

20528610

22 August 2017

Christopher Baum

series ordinal

3

1 reference

PubMed ID

20528610

22 August 2017

language of work or name

English

0 references

publication date

1 July 2010

1 reference

Expert Opinion on Biological Therapy

22 August 2017

1 reference

22 August 2017

10

1 reference

22 August 2017

7

1 reference

22 August 2017

1089-1103

1 reference

Forcing cells to change lineages

22 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Direct conversion of fibroblasts to functional neurons by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Embryonic stem cell lines derived from human blastocysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Viable offspring derived from fetal and adult mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Induction of dedifferentiation, genomewide transcriptional programming, and epigenetic reprogramming by extracts of carcinoma and embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Nuclei of embryonic stem cells reprogram somatic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

In vitro differentiation of reprogrammed murine somatic cells into hepatic precursor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Induced pluripotent stem cell lines derived from human somatic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Oct4-induced pluripotency in adult neural stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Generation of induced pluripotent stem cells using recombinant proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Strategies and new developments in the generation of patient-specific pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Core transcriptional regulatory circuitry in human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

An extended transcriptional network for pluripotency of embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Gene regulation and epigenetic remodeling in murine embryonic stem cells by c-Myc

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Myc influences global chromatin structure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Transcriptional regulation and transformation by Myc proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Generation of germline-competent induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Direct cell reprogramming is a stochastic process amenable to acceleration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Immortalization eliminates a roadblock during cellular reprogramming into iPS cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Suppression of induced pluripotent stem cell generation by the p53-p21 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Linking the p53 tumour suppressor pathway to somatic cell reprogramming

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

The Ink4/Arf locus is a barrier for iPS cell reprogramming

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

The ground state of embryonic stem cell self-renewal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Promotion of reprogramming to ground state pluripotency by signal inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Reprogramming towards pluripotency requires AID-dependent DNA demethylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Vitamin C enhances the generation of mouse and human induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

A chemical approach to stem-cell biology and regenerative medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

New strategies to generate induced pluripotent stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Virus-free induction of pluripotency and subsequent excision of reprogramming factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Reprogramming of murine and human somatic cells using a single polycistronic vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Induced pluripotent stem cell generation using a single lentiviral stem cell cassette

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Retroviral vector silencing during iPS cell induction: an epigenetic beacon that signals distinct pluripotent states

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Tight control of gene expression in mammalian cells by tetracycline-responsive promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Transcriptional activation by tetracyclines in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Protein transduction from retroviral Gag precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Polycistronic lentiviral vector for "hit and run" reprogramming of adult skin fibroblasts to induced pluripotent stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Induced pluripotent stem cells generated without viral integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Generation of mouse induced pluripotent stem cells without viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Generation of mouse-induced pluripotent stem cells by transient expression of a single nonviral polycistronic vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Human induced pluripotent stem cells free of vector and transgene sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Meganucleases and DNA double-strand break-induced recombination: perspectives for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Zinc-finger nucleases: the next generation emerges

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Progress and prospects: zinc-finger nucleases as gene therapy agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Zinc-finger nucleases meet iPS cells: Zinc positive: tailored genome engineering meets reprogramming

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Zinc Finger Tools: custom DNA-binding domains for transcription factors and nucleases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Zinc Finger Targeter (ZiFiT): an engineered zinc finger/target site design tool.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Rapid "open-source" engineering of customized zinc-finger nucleases for highly efficient gene modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Oligomerized pool engineering (OPEN): an 'open-source' protocol for making customized zinc-finger arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Regulation of DNA double-strand break repair pathway choice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Altering the genome by homologous recombination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

The promise of human induced pluripotent stem cells for research and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Patient-specific pluripotent stem cells: promises and challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Generation of induced pluripotent stem cells from human cord blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Disease-specific induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Phenotypic correction of murine hemophilia A using an iPS cell-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Complete genetic correction of ips cells from Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Generation of pluripotent stem cells from patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Technical challenges in using human induced pluripotent stem cells to model disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Progress toward the clinical application of patient-specific pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

HLA-haplotype banking and iPS cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Prospects for stem cell-based therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Regulatory networks define phenotypic classes of human stem cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Recurrent chromosomal abnormalities in human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Clone- and gene-specific aberrations of parental imprinting in human induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Generation of induced pluripotent stem cells from adult rhesus monkey fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Generation of induced pluripotent stem cell lines from Tibetan miniature pig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Mouse meningiocytes express Sox2 and yield high efficiency of chimeras after nuclear reprogramming with exogenous factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Hematopoietic and endothelial differentiation of human induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Induced pluripotent stem cells from a spinal muscular atrophy patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Stepwise differentiation of pluripotent stem cells into retinal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Generation of functional human hepatic endoderm from human induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Ten years of gene therapy for primary immune deficiencies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

The US and EU regulatory perspectives on the clinical use of hematopoietic stem/progenitor cells genetically modified ex vivo by retroviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Gene therapy of MPL deficiency: challenging balance between leukemia and pancytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Tumor cells escape suicide gene therapy by genetic and epigenetic instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

Elite and stochastic models for induced pluripotent stem cell generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.496775

10.1517/14712598.2010.496775

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20528610